Extrawell Pharmaceutical Holdings Ltd
HKEX:858
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Extrawell Pharmaceutical Holdings Ltd
HKEX:858
|
HK |
|
G-Tekt Corp
TSE:5970
|
JP |
|
Pidilite Industries Ltd
NSE:PIDILITIND
|
IN |
|
M
|
Material Group Inc
TSE:156A
|
JP |
|
S
|
Sixt SE
LSE:0NW7
|
DE |
|
Anglesey Mining PLC
LSE:AYM
|
UK |
|
WA Inc
TSE:7683
|
JP |
|
Batisoke Soke Cimento Sanayii TAS
IST:BSOKE.E
|
TR |
|
V
|
VersaBank
TSX:VBNK
|
CA |
|
Triller Group Inc
NASDAQ:ILLR
|
US |
Extrawell Pharmaceutical Holdings Ltd
Extrawell Pharmaceutical Holdings Ltd. engages in the marketing and distribution of pharmaceutical products. The company employs 169 full-time employees The firm mainly operates through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its manufactured products include Transfer Factor Oral Solution, Wisk and ZhouBang, among others. The Trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Its imported products include GM 1, Millibar and Skin Cap. The Gene Development segment is engaged in the commercial exploitation and development of genome-related technologies.
Extrawell Pharmaceutical Holdings Ltd. engages in the marketing and distribution of pharmaceutical products. The company employs 169 full-time employees The firm mainly operates through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its manufactured products include Transfer Factor Oral Solution, Wisk and ZhouBang, among others. The Trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Its imported products include GM 1, Millibar and Skin Cap. The Gene Development segment is engaged in the commercial exploitation and development of genome-related technologies.
